Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ablation with low-dose radioiodine and thyrotropin alfa in thyroid cancer.
Mallick U, Harmer C, Yap B, Wadsley J, Clarke S, Moss L, Nicol A, Clark PM, Farnell K, McCready R, Smellie J, Franklyn JA, John R, Nutting CM, Newbold K, Lemon C, Gerrard G, Abdel-Hamid A, Hardman J, Macias E, Roques T, Whitaker S, Vijayan R, Alvarez P, Beare S, Forsyth S, Kadalayil L, Hackshaw A. Mallick U, et al. N Engl J Med. 2012 May 3;366(18):1674-85. doi: 10.1056/NEJMoa1109589. N Engl J Med. 2012. PMID: 22551128 Free article. Clinical Trial.
Well-being after radiation therapy in thyroid cancer.
Hackshaw A, Kadalayil L, Mallick U. Hackshaw A, et al. Among authors: mallick u. N Engl J Med. 2013 Feb 14;368(7):685-6. doi: 10.1056/NEJMc1212592. N Engl J Med. 2013. PMID: 23406048 No abstract available.
Recurrence after low-dose radioiodine ablation and recombinant human thyroid-stimulating hormone for differentiated thyroid cancer (HiLo): long-term results of an open-label, non-inferiority randomised controlled trial.
Dehbi HM, Mallick U, Wadsley J, Newbold K, Harmer C, Hackshaw A. Dehbi HM, et al. Among authors: mallick u. Lancet Diabetes Endocrinol. 2019 Jan;7(1):44-51. doi: 10.1016/S2213-8587(18)30306-1. Epub 2018 Nov 27. Lancet Diabetes Endocrinol. 2019. PMID: 30501974 Free PMC article. Clinical Trial.
Optimizing the management of differentiated thyroid cancer.
Mallick UK, Lucraft H, Proud G, Perros P, Fenwick J, Kendall-Taylor P, Johnson S, Lennard T, Ball S, James RA, Douglas F, Weightman DR. Mallick UK, et al. Clin Oncol (R Coll Radiol). 2000;12(6):363-4. doi: 10.1053/clon.2000.9195. Clin Oncol (R Coll Radiol). 2000. PMID: 11202089 No abstract available.
Elevated PTTG and PBF predicts poor patient outcome and modulates DNA damage response genes in thyroid cancer.
Read ML, Fong JC, Modasia B, Fletcher A, Imruetaicharoenchoke W, Thompson RJ, Nieto H, Reynolds JJ, Bacon A, Mallick U, Hackshaw A, Watkinson JC, Boelaert K, Turnell AS, Smith VE, McCabe CJ. Read ML, et al. Among authors: mallick u. Oncogene. 2017 Sep 14;36(37):5296-5308. doi: 10.1038/onc.2017.154. Epub 2017 May 15. Oncogene. 2017. PMID: 28504713 Free PMC article.
46 results